BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

543 related articles for article (PubMed ID: 9292286)

  • 1. Are we ready to replace dimercaprol (BAL) as an arsenic antidote?
    Mückter H; Liebl B; Reichl FX; Hunder G; Walther U; Fichtl B
    Hum Exp Toxicol; 1997 Aug; 16(8):460-5. PubMed ID: 9292286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DMSA, DMPS, and DMPA--as arsenic antidotes.
    Aposhian HV; Carter DE; Hoover TD; Hsu CA; Maiorino RM; Stine E
    Fundam Appl Toxicol; 1984 Apr; 4(2 Pt 2):S58-70. PubMed ID: 6327446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of various dithiol compounds in acute As2O3 poisoning in mice.
    Kreppel H; Reichl FX; Szinicz L; Fichtl B; Forth W
    Arch Toxicol; 1990; 64(5):387-92. PubMed ID: 2169719
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of various antidotes on the biliary and intestinal excretion of arsenic in situ and into the feces in vivo in guinea-pigs after injection of As2O3.
    Reichl FX; Kreppel H; Szinicz L; Mückter H; Fichtl B; Forth W
    Arch Toxicol; 1994; 69(1):35-8. PubMed ID: 7536408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DMSA and DMPS--water soluble antidotes for heavy metal poisoning.
    Aposhian HV
    Annu Rev Pharmacol Toxicol; 1983; 23():193-215. PubMed ID: 6307120
    [No Abstract]   [Full Text] [Related]  

  • 6. Lack of effectiveness of D-penicillamine in experimental arsenic poisoning.
    Kreppel H; Reichl FX; Forth W; Fichtl B
    Vet Hum Toxicol; 1989 Feb; 31(1):1-5. PubMed ID: 2540587
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arsenic Toxicity: Molecular Targets and Therapeutic Agents.
    Nurchi VM; Djordjevic AB; Crisponi G; Alexander J; Bjørklund G; Aaseth J
    Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32033229
    [No Abstract]   [Full Text] [Related]  

  • 8. Therapeutic potential of meso 2,3-dimercaptosuccinic acid or 2,3-dimercaptopropane 1-sulfonate in chronic arsenic intoxication in rats.
    Flora SJ; Dube SN; Arora U; Kannan GM; Shukla MK; Malhotra PR
    Biometals; 1995 Apr; 8(2):111-6. PubMed ID: 7734923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of dimercapto chelating agents for the treatment of poisoning by percutaneously applied dichloro(2-chlorovinyl)arsine in rabbits.
    Inns RH; Rice P
    Hum Exp Toxicol; 1993 May; 12(3):241-6. PubMed ID: 8100435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of various antidotes on biliary excretion of arsenic in isolated perfused livers of guinea pigs after acute experimental poisoning with As2O3.
    Reichl FX; Mückter H; Kreppel H; Forth W
    Pharmacol Toxicol; 1992 May; 70(5 Pt 1):352-6. PubMed ID: 1608923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metal chelators and neurotoxicity: lead, mercury, and arsenic.
    Bjørklund G; Mutter J; Aaseth J
    Arch Toxicol; 2017 Dec; 91(12):3787-3797. PubMed ID: 29063135
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-lewisite activity and stability of meso-dimercaptosuccinic acid and 2,3-dimercapto-1-propanesulfonic acid.
    Aposhian HV; Mershon MM; Brinkley FB; Hsu CA; Hackley BE
    Life Sci; 1982 Nov; 31(19):2149-56. PubMed ID: 6294430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of three antidotes on arsenic toxicity in the common earthworm (Lumbricus terrestris).
    Li W; Chien PK; Furst A
    J Appl Toxicol; 1994; 14(3):181-3. PubMed ID: 7521893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the efficacy of dimercapto chelating agents for the treatment of systemic organic arsenic poisoning in rabbits.
    Inns RH; Rice P; Bright JE; Marrs TC
    Hum Exp Toxicol; 1990 Jul; 9(4):215-20. PubMed ID: 2167707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S; Vale A
    Clin Toxicol (Phila); 2009 Nov; 47(9):841-58. PubMed ID: 19852620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Isolated rat kidney tubules as a screening system for arsenic antidotes.
    Mückter H; Islambouli S; Doklea E; Hopfer C; Szinicz L; Fichtl B; Forth W
    Toxicol Appl Pharmacol; 1993 Jul; 121(1):118-28. PubMed ID: 8393218
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of chelation in the treatment of arsenic and mercury poisoning.
    Kosnett MJ
    J Med Toxicol; 2013 Dec; 9(4):347-54. PubMed ID: 24178900
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,3-Dithioerythritol, a possible new arsenic antidote.
    Boyd VL; Harbell JW; O'Connor RJ; McGown EL
    Chem Res Toxicol; 1989; 2(5):301-6. PubMed ID: 2562424
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical efficacy of dimercapto-chelating agents against lewisite-induced skin lesions in SKH-1 hairless mice.
    Mouret S; Wartelle J; Emorine S; Bertoni M; Nguon N; Cléry-Barraud C; Dorandeu F; Boudry I
    Toxicol Appl Pharmacol; 2013 Oct; 272(2):291-8. PubMed ID: 23806213
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mobilization of heavy metals by newer, therapeutically useful chelating agents.
    Aposhian HV; Maiorino RM; Gonzalez-Ramirez D; Zuniga-Charles M; Xu Z; Hurlbut KM; Junco-Munoz P; Dart RC; Aposhian MM
    Toxicology; 1995 Mar; 97(1-3):23-38. PubMed ID: 7716789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.